HLA-DQA1 HLA-DQ Autoimmune Tag SNP

The HLA-DQ Immune Recognition Gateway

Deep inside chromosome 6 lies the major histocompatibility complex (MHC) — the
most gene-dense region of the human genome and the strongest known genetic determinant
of autoimmune disease. rs2040410 sits within this region, just downstream of the
HLA-DQA1 | Human Leukocyte Antigen DQ alpha-1 chain gene.
It acts as a tag marker: its T allele (reported as "A" in some older publications
using the minus-strand convention) travels in near-perfect linkage with DRB1*0301,
the allele that defines the DR3 branch of the highest-risk type 1 diabetes haplotype.

The Mechanism

HLA-DQ molecules are heterodimeric proteins assembled from an alpha chain (encoded
by DQA1) and a beta chain (encoded by DQB1). Together they form a peptide-binding
groove that presents antigens to CD4+ T cells. The specific shape of this groove —
determined by which DQA1 and DQB1 alleles you carry — determines which peptides
trigger immune responses and which are ignored.

The DR3 haplotype (DRB1*0301-DQA1*0501-DQB1*0201, also called DR3-DQ2) forms a
groove with unusual binding properties: it presents a wide range of self-peptides
and foreign antigens, but it also skews thymic selection of T cells in ways that
increase susceptibility to autoimmune activation.
HLA-DQ2 | The DQ2 heterodimer is present in approximately 95% of celiac disease
patients, and DQ2 homozygotes face a substantially higher risk than heterozygotes.
The DR3-DQ2 haplotype is independently associated with type 1 diabetes, SLE,
Sjögren's syndrome, and other conditions in which loss of tolerance to self-antigens
is the central event.

rs2040410 itself is a non-coding downstream variant; it does not change any protein.
Its value is as a proxy: the T allele captures the DR3 haplotype status from a
standard SNP array, enabling high-throughput identification without the labour-intensive
HLA typing | Traditional high-resolution HLA typing involves sequencing the DRB1,
DQA1, and DQB1 loci directly — a process that costs ~$30 per sample versus ~$6 for
SNP-based screening required
for classical allele calling.

The Evidence

Barker et al. 2008 | Barker JM et al. Two single nucleotide polymorphisms identify the
highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes 2008;57(11):3152-5.
established rs2040410 as a tag for DRB1*0301 (R²=0.872) and showed that combining
this SNP with rs7454108 (which tags DQB1*0302) identifies the DR3/4-DQ8 compound
heterozygous genotype with 98.5% sensitivity and 99.7% specificity across 5,019
participants from the Type 1 Diabetes Genetics Consortium. In an independent DAISY
cohort this rose to 100% sensitivity and specificity. The DR3/4-DQ8 genotype — marked
by carrying both the T allele at rs2040410 and the C allele at rs7454108 — accounts
for roughly 30–50% of childhood-onset type 1 diabetes cases in European populations.

Aly et al. 2006 | Aly TA et al. Extreme genetic risk for type 1A diabetes. PNAS
2006;103(38):14074-9.
followed siblings of type 1 diabetes probands who carried the DR3/4-DQ8 genotype
and shared both HLA haplotypes with their affected sibling. Cumulative risk of islet
autoimmunity reached 85% by age 15 — describing what the authors called "extreme
genetic risk," three to four times higher than previously reported for any HLA
configuration.

Beyond type 1 diabetes, the DR3 haplotype (and therefore the T allele at rs2040410)
is consistently associated with systemic lupus erythematosus, Sjögren's syndrome,
and sarcoidosis — conditions all involving dysregulated immune recognition of
self-antigens through the DR3-DQ2 peptide-presentation axis.

Practical Actions

Carrying the T allele at rs2040410 does not mean you have or will develop type 1
diabetes or another autoimmune condition — DR3/4-DQ8 homozygotes in the general
population have approximately 5% autoantibody prevalence by age 7.
The risk is probabilistic and context-dependent. For carriers, the clinically
actionable steps focus on monitoring for the earliest signs of autoimmune activation,
since several conditions in the DR3-DQ2 risk constellation respond well to early
intervention. Coeliac screening is particularly relevant because DQ2 (encoded by
the DQA1*0501-DQB1*0201 alleles that travel with this haplotype) is a necessary
precondition for gluten-triggered autoimmunity.

Interactions

rs2040410 (DR3 tag) and rs7454108 (DQ8 tag, DQB1*0302 proxy) are used together
to identify the compound DR3/4-DQ8 genotype — the highest-risk type 1 diabetes
HLA configuration. Individuals heterozygous for both markers (AG at rs7454108 and
CT at rs2040410) merit the highest clinical vigilance. The interaction is not additive
in a simple sense: the DR3/4-DQ8 combination confers significantly more risk than
either the DR3 or DR4 haplotype alone, because the trans DQ heterodimer
(DQA1*0301/DQB1*0201) is itself a high-affinity presenter of self-peptides.